Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Exp Mol Pathol. 2011 Jan 15;90(3):244–251. doi: 10.1016/j.yexmp.2011.01.002

Table 1.

Genes up-regulated more than 4 fold in angiocidin-treated MB-231 cells as detected by PCR Array

Gene Function Fold Increase Reference
TLR2 Immune cell receptor, promotes cytokine production through NFkB pathway, improve chemotherapy 34.3 (Garay et al., 2007)
IFNG Immune cytokine, inhibits breast cancer proliferation 16 (Iacopino et al., 1997)
IFNB1 Immune cytokine, inhibits breast cancer proliferation 10.6 (Sica et al., 1987)
NR2C2/TR4 Orphan nuclear receptor 8 (Shyr et al., 2002)
PELI1 E3 ubiquitin ligase, promotes cytokine synthesis 7.5 (Chang et al., 2009)
REL a member of the NFκB family of transcription factors. 6.5 (Biswas et al., 2004)
CD180 a member of the Toll-like receptors 6.1 (Aderem and Ulevitch, 2000)
MAPK8IP3 protein kinase, regulates the activity of numerous protein kinases of the JNK signaling pathway 5.3 (Davis, 2000)
CSF2/GM- CSF Anti-tumorigenic cytokine in breast cancer 4.9 (Eubank et al., 2009)
MAP4K4 Protein kinase, upregulated p53 and drives c- Jun NH2-terminal kinase (JNK) Mediated apoptosis 4.0 (Miled et al., 2005)
IL1B Inflammatory cytokine, promotes leukocyte differentiation, inhibits breast proliferation 4.0 (Roy et al., 2006)
c-FOS Proto-oncogene important in breast cancer proliferation 4.0 (van der Burg et al., 1989)